fig13
![Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention](https://image.oaes.cc/90c048c1-30a0-44b1-9c79-c69588a02257/2317.fig.13.png)
Figure 13. Androgen receptor ligand-binding protein antagonists approved by FDA or in clinical trials
Figure 13. Androgen receptor ligand-binding protein antagonists approved by FDA or in clinical trials
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/